Geneva, Switzerland, 18 November 2014 – ObsEva, a Swiss biopharmaceutical company dedicated to the development and commercialization of innovative drugs…
Tag: 2014
ObsEva SA appoints Ben T.G. Tan as VP Commercial & Business Development
Geneva, Switzerland, 10 September 2014 – ObsEva, a Swiss-based, specialty biopharmaceutical company dedicated to the development and commercialisation of innovative…
ObsEva SA announced today it was granted JEDI status and European SME status
Geneva, Switzerland, 23 July 2014 – ObsEva, a Swiss-based, specialty biopharmaceutical company dedicated to the development of innovative drugs for…
ObsEva SA Announces Appointments to its Board of Directors and Scientific Advisory Board
Geneva, Switzerland, 17 January 2014 – ObsEva, a Swiss-based, speciality biopharmaceutical company dedicated to the development of innovative drugs for…